Patents by Inventor Michael T. Lam

Michael T. Lam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of enhancer RNA mediated gene expression
    Patent number: 9518261
    Abstract: Disclosed herein are methods and compounds for inhibiting gene expression by inhibiting enhancer RNAs (eRNAs). Such methods and compounds are useful for reducing expression of certain genes, many of which are associated with a variety of diseases and disorders.
    Type: Grant
    Filed: May 22, 2013
    Date of Patent: December 13, 2016
    Assignees: Ionis Pharmaceuticals, Inc., The Regents of the University of California
    Inventors: Susan M. Freier, Christopher K. Glass, Michael G. Rosenfeld, Wenbo Li, Michael T. Lam
  • MODULATION OF ENHANCER RNA MEDIATED GENE EXPRESSION
    Publication number: 20150176005
    Abstract: Disclosed herein are methods and compounds for inhibiting gene expression by inhibiting enhancer RNAs (eRNAs). Such methods and compounds are useful for reducing expression of certain genes, many of which are associated with a variety of diseases and disorders.
    Type: Application
    Filed: May 22, 2013
    Publication date: June 25, 2015
    Applicants: The Regents of the University of California, Isis Pharmaceuticals, Inc.
    Inventors: Susan M. Freier, Christopher K. Glass, Michael G. Rosenfeld, Wenbo Li, Michael T. Lam